This page shows the latest burns treatment news and features for those working in and with pharma, biotech and healthcare.
Stratatech’s StrataGraft in phase III testing for burns treatment. Ireland's Mallinckrodt Pharma has continued its acquisitive streak with a deal to buy Stratatech, a US firm developing a biologic ... treatment for severe burns.
Advanced stomach cancer is a devastating disease for which there are currently few treatment options," said William M. ... Burns, CEO of Roche's Pharmaceuticals Division. Stomach cancer is the second most common cause of cancer-related death in the world.
Mediwound, which is also based in Israel, specialises in technology to treat burns. ... Ruben Krupik, CEO of Clal Biotechnology Industries, said that the burns treatment market was worth USD 400-500m annually.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
No results were found
Wallace Health is a healthcare and medical content agency with a successful track record of delivering web content, content marketing...